Short communicationAntidepressant-like effects of ALNESPIRONE (cas 138277-78-8) (S 20499) in the learned helplessness test in rats

Add time:08/19/2019    Source:sciencedirect.com

The effects of the new chroman derivative, ALNESPIRONE (cas 138277-78-8) (S 20499), which is a selective 5-HT1A receptor agonist, were investigated in an animal model of depression, the learned helplessness test. Rats previously submitted to a session of 60 inescapable electric foot shocks (learned helpless controls) exhibited a deficit in escape performance in three subsequent shuttle-box sessions. Alnespirone was administered twice daily via the oral route (2.5, 5, 10, 20 mg kg−1 day−1). It was shown to protect against the elevation in escape failures caused by exposure to the uncontrollable aversive situation at 5 and 10 mg kg−1 day−1 p.o. (13±2 and 10±3 escape failures, respectively, vs. 9±2 escape failures in control rats). In addition, alnespirone had a tendency to elevate the number of intertrial crossings during the resting periods, depending on the dose and day on which the avoidance task was performed (15±2 intertrial crossings at the dose of 5 mg kg−1 day−1, vs. 5±2 intertrial crossings for the helpless control rats, on the second day). In comparison, imipramine (64 mg kg−1 day−1 p.o.) provided marked protection on all three days of the avoidance task and tended to increase the number of intertrial crossings during the resting periods on the second and the third days. It is concluded that alnespirone exerts antidepressant-like properties in the learned helplessness test in rats, in a manner similar to 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin), buspirone and ipsapirone, other 5-HT1A receptor agonists.

We also recommend Trading Suppliers and Manufacturers of ALNESPIRONE (cas 138277-78-8). Pls Click Website Link as below: cas 138277-78-8 suppliers

Prev:In vivo comparison of two 5-HT1A receptors agonists ALNESPIRONE (cas 138277-78-8) (S-20499) and buspirone on locus coeruleus neuronal activity
Next:ArticlesALNESPIRONE (cas 138277-78-8) (S 20499), an Agonist of 5-HT1A Receptors, and Imipramine Have Similar Activity in a Chronic Mild Stress Model of Depression)